{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-025055","form_type":"8-K","ticker":"MIST","cik":"0001408443","company_name":"Milestone Pharmaceuticals Inc.","filed_at":"2025-03-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.543225+00:00","generated_at":"2026-05-24T13:26:08.529338+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Milestone Pharmaceuticals amends ATM sales agreement with Jefferies to up to $77.8M","bullets":["Amended Open Market Sale Agreement replaces prior $50M facility; total capacity increased to $77.8M including ~$2.8M already sold.","Common shares sold at-the-market via Jefferies; company pays 3.0% commission on gross proceeds.","Prospectus supplement to be filed under existing S-3 shelf registration (File No. 333-283162).","Company not obligated to sell any shares; agreement may be terminated early by either party."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-025055","json":"https://secwatch.observer/filing/0001104659-25-025055.json","markdown":"https://secwatch.observer/filing/0001104659-25-025055.md","text":"https://secwatch.observer/filing/0001104659-25-025055.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1408443/000110465925025055/0001104659-25-025055-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1408443/000110465925025055/tm259429d2_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T13:26:08.529338+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}